Horizon Therapeutics plc (Nasdaq: HZNP) today announced updates on its 2020 financial results, TEPEZZA supply and new KRYSTEXXA trials. “Amid the most challenging environment we have ever faced, we had a record year of performance, exceeding our …

Wertpapier:

Horizon Therapeutics plc (Nasdaq: HZNP) announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supply as a result of recent government-mandated COVID-19 vaccine production orders related to Operation Warp Speed that have …

Wertpapier:

Nachrichten

ZeitTitel
03.12.20
02.12.20
30.11.20
25.11.20
23.11.20
17.11.20
16.11.20
13.11.20
13.11.20
12.11.20
02.11.20
02.11.20
02.11.20
30.10.20
30.10.20
Diskussionen

Horizon Therapeutics Forum

Die wichtigsten Links der Community
Forum-Suche

Diskussionen

Was halten Sie von den neusten Entwicklungen zu Horizon Therapeutics?